Table 4.
Risk of Adverse Outcomes by Glucose Homeostasis Parameters
| RR and 95% CI per 1‐SD Increase (z score) | χ2 | P Value | |
|---|---|---|---|
| Glucose, fasting | 0.69 (0.53–0.86) | 8.0 | 0.005 |
| OGT at 30 min | 0.70 (0.53–0.91) | 7.0 | 0.008 |
| OGT at 60 min | 0.79 (0.62–1.01) | 3.6 | 0.06 |
| OGT at 120 min | 0.99 (0.78–1.26) | 0.1 | 0.9 |
| Insulin, fasting | 0.85 (0.62–1.12) | 1.2 | 0.3 |
| OGT at 30 min | 1.01 (0.76–1.26) | 0.1 | 0.9 |
| OGT at 60 min | 0.99 (0.76–1.25) | 0.1 | 0.9 |
| OGT at 120 min | 1.05 (0.78–1.32) | 0.1 | 0.7 |
| C‐peptide, fasting | 1.30 (1.0–1.67) | 3.9 | 0.05 |
| OGT at 30 min | 1.13 (0.87–1.43) | 0.9 | 0.4 |
| OGT at 60 min | 1.09 (0.84–1.42) | 0.5 | 0.5 |
| OGT at 120 min | 1.14 (0.88–1.48) | 1.0 | 0.3 |
| Glucagon, fasting | 1.32 (1.06–1.60) | 5.8 | 0.01 |
| OGT at 30 min | 1.09 (0.83–1.37) | 0.4 | 0.5 |
| OGT at 60 min | 1.00 (0.99–1.01) | 0.1 | 0.8 |
| OGT at 120 min | 1.17 (0.91–1.44) | 1.7 | 0.2 |
CI indicates confidence interval; OGT, oral glucose tolerance test; RR, relative risk.